Targeting of EWS-FLI1 as anti-tumor therapy
US9758481B2 · kind B2 · utility
8Cited by
6References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2015 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Apr 24, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides and compounds are provided that function as EWS-FLI1 protein inhibitors. The peptides and compounds have utility in the treatment of Ewing's sarcoma family of tumors. Also provided are methods of preparing the compounds and assays for identifying inhibitors of EWS-FLI1 protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.